John Hilterman/LinkedIn
Nov 5, 2025, 05:09
Rethinking Anticoagulants in Hospice
John Hilterman, Business Development Manager at Wise Hospice Option, posted on LinkedIn:
”Safer care starts with clearer insight.
For many hospice patients, the goal shifts from prevention to comfort – and that means re-evaluating medications like anticoagulants and antiplatelets.
Our latest Hospice Pharmacist’s Brief outlines when deprescribing is clinically appropriate, how to manage risk, and ways to align therapy with quality-of-life goals.”
Read more here.
Keep up with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia